InvestorsHub Logo
Followers 15
Posts 1086
Boards Moderated 0
Alias Born 04/12/2011

Re: None

Thursday, 04/08/2021 12:12:52 AM

Thursday, April 08, 2021 12:12:52 AM

Post# of 1166

LumiraDx partnered with Chembio Diagnostics to develop a COVID-19 diagnostic for its microfluidic point-of-care testing system in March 2020.

On April 7, 2021, LuminarDX announced that it will combine with CA Healthcare Acquisition Corp, in a deal that values LumiraDx’s equity at $5 billion

https://www.businesswire.com/news/home/20210406006194/en/LumiraDx-a-Next-Generation-Point-of-Care-Diagnostics-Testing-Company-to-List-on-Nasdaq-via-Merger-with-CA-Healthcare-Acquisition-Corp